Billev Pharma East at the Slovenian Pharmaceutical Society Symposium showcased its commitment to regulatory excellence and innovation during the 50th anniversary congress in Portorož. From May 8–10, our team actively participated in discussions shaping the future of the pharmaceutical industry, highlighting key developments in compliance and digital transformation.
Expert Presentation on Electronic Product Information (ePI) by Billev Pharma East at the Slovenian Pharmaceutical Society Symposium – 50th SFD Congress 2025
At Billev Pharma East at the Slovenian Pharmaceutical Society Symposium, held as part of the 50th SFD Congress 2025 in Slovenia, Katja Pečjak Reven once again stood out as a speaker with a compelling presentation on electronic Product Information (ePI). As the only lecture on this topic during the three-day event, it underscored the growing relevance of ePI in the pharmaceutical sector. She presented cutting-edge industry trends, provided expert insights, and actively engaged with participants in dynamic discussions.
This significant topic was a fitting addition to the 50th anniversary of the SFD Assembly, aligning perfectly with the ongoing digital transformation in the pharmaceutical sector. Billev Pharma East at the Slovenian Pharmaceutical Society Symposium emphasized how electronic Product Information (ePI) directly supports our advisory services in regulatory affairs for human medicines, as we help pharmaceutical companies navigate the evolving landscape of digitalization and compliance.
Billev Pharma East at the Slovenian Pharmaceutical Society Symposium: A Premier Pharmaceutical Forum at the 50th SFD Congress 2025 in the Region
The SFD Congress is the largest pharmaceutical event in Slovenia and serves as a key gathering point for professionals from public and hospital pharmacies, pharmaceutical companies, academia, regulatory bodies, and industry exhibitors. This year’s agenda covered highly relevant themes, including innovations in pharmacy, menopause, and the treatment of asthma and COPD.
Particularly noteworthy was a session focused on the digitalization of drug information, highlighting the opportunities and challenges it presents for manufacturers, importers, healthcare providers, and pharmacists. Billev Pharma East at the Slovenian Pharmaceutical Society Symposium contributed actively to these conversations, reinforcing our dedication to supporting digital transformation and regulatory excellence in the pharmaceutical landscape.
Innovative Insights from Billev Pharma East at the Slovenian Pharmaceutical Society Symposium, 50th SFD Congress 2025
For Billev Pharma East, participating in such events is a valuable opportunity to stay at the forefront of regulatory and scientific developments, exchange knowledge with top experts, and establish new partnerships. It reinforces our mission to drive innovation, continuous professional development, and operational excellence.
We believe the insights gained at the congress will fuel new initiatives and support the ongoing education of our experts — helping us to maintain and enhance our competitive edge in pharmaceutical and medical device regulatory affairs. These outcomes highlight the importance of Billev Pharma East at the Slovenian Pharmaceutical Society Symposium and our continued presence at key industry events like the 50th SFD Congress 2025 in Slovenia.
Embracing Digital Transformation: The Role of ePI in Modern Pharmaceuticals
A central focus of the 50th SFD Congress 2025 in Slovenia was the digital evolution reshaping the pharmaceutical industry, especially the transition from conventional paper-based documentation to integrated digital systems. Billev Pharma East at the Slovenian Pharmaceutical Society Symposium contributed to this vital discourse by highlighting practical implications and regulatory considerations of this digital shift.
Among the most significant changes is the implementation of electronic Product Information (ePI), a topic that Billev Pharma East’s own Katja Pečjak Reven addressed in her well-received presentation.
The move toward ePI reflects a broader push within the European Union and globally to enhance access to up-to-date, accurate, and user-friendly information for patients, healthcare professionals, and regulators. By replacing static printed leaflets with dynamic, digital formats, ePI can offer a number of advantages, including:
- Real-time updates to product information.
- Improved accessibility, particularly for patients with visual impairments or language barriers.
- Integration with digital health tools to provide a holistic view of treatment options.
- Environmental sustainability by reducing paper usage.
At Billev Pharma East at the Slovenian Pharmaceutical Society Symposium, Katja Pečjak Reven shed light on both the opportunities and challenges of the industry’s digital transition. While digitalization offers clear benefits, pharmaceutical companies must carefully address regulatory complexity, uphold data integrity, and invest in appropriate technological solutions. She also emphasized that the successful implementation of these changes depends heavily on active engagement from all stakeholders — including healthcare professionals and patients.
At Billev Pharma East, we see this transformation not just as a regulatory obligation but as an opportunity to lead innovation in pharmaceutical communication. Our experience in regulatory affairs, coupled with our proactive approach to digital solutions, positions us well to support clients and partners as they adapt to this evolving landscape.
As we can see, ePI adoption is accelerating worldwide, and Billev Pharma East is at the forefront of this transformation. By staying ahead of digital trends and maintaining a focus on patient-centric communication, we are well-equipped to support the future of pharmaceutical innovation.
Participation in the 50th SFD Congress 2025 in Slovenia provided a valuable platform for Billev Pharma East to exchange views with other industry leaders, explore real-world use cases, and stay updated on the latest trends and expectations from regulatory authorities such as the EMA and national competent bodies.
As digital health continues to evolve, Billev Pharma East at the Slovenian Pharmaceutical Society Symposium reaffirms its commitment to sharing expertise, fostering meaningful industry dialogue, and shaping a future where information is more accessible, accurate, and patient-focused.
Recommended reading: